NeuroOne Medical Technologies Corporation
NMTC
$0.80
-$0.01-0.87%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.72M | 12.10M | 6.63M | 5.76M | 5.75M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.72M | 12.10M | 6.63M | 5.76M | 5.75M |
| Cost of Revenue | 7.68M | 7.48M | 6.40M | 6.17M | 6.57M |
| Gross Profit | 4.04M | 4.61M | 230.90K | -414.20K | -816.60K |
| SG&A Expenses | 7.23M | 7.38M | 7.45M | 7.71M | 7.77M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 3.00M | 0.00 | -3.00M | -3.00M | -3.00M |
| Total Operating Expenses | 19.36M | 16.32M | 12.30M | 12.34M | 12.54M |
| Operating Income | -7.65M | -4.23M | -5.67M | -6.58M | -6.79M |
| Income Before Tax | -6.83M | -3.61M | -5.34M | -6.60M | -7.19M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.83 | -3.61 | -5.34 | -6.60 | -7.19 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.83M | -3.61M | -5.34M | -6.60M | -7.19M |
| EBIT | -7.65M | -4.23M | -5.67M | -6.58M | -6.79M |
| EBITDA | -7.38M | -3.96M | -5.41M | -6.32M | -6.53M |
| EPS Basic | -0.16 | -0.08 | -0.16 | -0.23 | -0.27 |
| Normalized Basic EPS | -0.10 | -0.06 | -0.12 | -0.16 | -0.17 |
| EPS Diluted | -0.17 | -0.08 | -0.16 | -0.23 | -0.27 |
| Normalized Diluted EPS | -0.10 | -0.06 | -0.12 | -0.16 | -0.17 |
| Average Basic Shares Outstanding | 180.11M | 160.61M | 140.36M | 119.11M | 113.91M |
| Average Diluted Shares Outstanding | 180.11M | 160.66M | 140.41M | 119.16M | 113.95M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |